Platt, RPh LLC. The current location address for Advanced Infusion Solutions is 18451 Dallas Pkwy Ste 125, , Dallas, Texas and the contact number is 877-443-4006 and fax number is --. Reason: The submitted appearance form does not match the registered attorney. Leagle.com reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions. . Advanced Infusion Solutions is a provider established in Ridgeland, Mississippi operating as a Pharmacy with a focus in home infusion therapy pharmacy . Physical address: Carr. 1:22-CV-00542 | 2022-06-13, U.S. District Courts | Civil Right | 2:21-CV-00774 | 2021-04-16, U.S. District Courts | Contract | [21-30534] (SEP) [Entered: 09/15/2021 03:32 PM], APPEARANCE FORM FILED by Attorney Timothy Richardson for Appellant Randy Denning in 21-30534. In fact, AIS contends that the Agreement expressly authorizes it to use S9328 code when it provides "professional pharmacy services" in the form of specially compounded medication to BCBS's subscribers, and therefore AIS did not breach the Agreement. Id. 4:22-CV-12577 | 2022-10-26, U.S. District Courts | Contract | No. (Entered: 05/12/2021), Docket(#23) NOTICE OF HEARING BY VIDEO CONFERENCE on #18 MOTION to Dismiss Plaintiff's Amended Complaint. 39, 40, 41, 42. (Cloutier, Kevin) (Entered: 04/29/2021), Docket(#21) RESPONSE to #18 MOTION to Dismiss Plaintiff's Amended Complaint filed by Blue Cross Blue Shield of Michigan. I must pay the remaining amount. (dba The Wellness Pharmacy), Winchester, VA- 503A Facility, Kalman Health & Wellness, Inc. (dba Essential Wellness Pharma), Peoria, IL- 503A Facility, Kelley-Ross Compounding Pharmacy, Seattle, WA- 503A Facility, Key Compounding Pharmacy (see Puget Sound Drug Corporation), Federal Way, WA- 503A Facility, Keystone Pharmacy, Grand Rapids, MI- 503A Facility, Keystone Rx LLC, Bensalem, PA- 503A Facility, Kings Park Slope, Inc., Brooklyn, NY- 503A Facility - De-registered as an Outsourcing Facility, Kohana Pharmacy and Center for Regenerative Medicine Inc., San Luis Obispo, CA- 503A Facility, Kohll's Compounding, Omaha, NE- 503A Facility, Kona Community Hospital Pharmacy, (see Hawaii Health Systems Corporation), Kealakekua, HI- 503A Facility, KRS Global Biotechnology, Inc. Boca Raton, FL- 503B Facility, Ladd Family Pharmacy LLC, Boise, ID- 503A Facility, Lato Drug Company, Inc. (dba Post Haste Pharmacy), Hollywood, FL- 503A Facility, La Vita Compounding Pharmacy, LLC, San Diego, CA- 503A Facility, Lee and Company (dba Lee Pharmacy, Inc.), Fort Smith, AR- 503A Facility - Out of business, Lee Pharmacy, Inc.(see Lee and Company), Fort Smith, AR- 503A Facility, LeeSar, Inc., Fort Myers, FL- 503B Facility, Lee Silsby Compounding Pharmacy, (see Gipsco Investment Corp.), Cleveland Heights, OH- 503A Facility, Leiter's Cambrian Park Drugs, Inc., (dbaLeiter's Compounding Pharmacy), 1700 Park Avenue, San Jose, CA- 503A Facility - Out of business, Leiter's Compounding, 17 Great Oaks Blvd., San Jose, CA- 503A Facility, Leiter's Compounding Pharmacy,(see Leiter's Cambrian Park Drugs, Inc.), San Jose, CA- 503A Facility, Leiter's Health, (see Denver Solutions, LLC), Englewood, CO- 503A Facility, Liberty Drug and Surgical, Chatham, NJ- 503A Facility, Life Science Pharmacy, Inc., Harriman, NY- 503A Facility, Lifetime Value Pharmacy III Inc., Santa Ana, CA- 503A Facility, Lincare, Inc. (dba United Medical Home Infusion), Little Rock, AR- 503A Facility, Lloyd Central Compounding Pharmacy, (see Portland Compounding Pharmacy, LLC), Portland, OR- 503A Facility, Loop Pharmacy & Home Medical, Saint Albans, WV- 503A Facility, Louisville Pharmacy (see Spoonamore Drug Co., Inc.), Louisville, KY- 503A Facility, Lowlite Investments, Inc. (dba Olympia Pharmacy), Orlando, FL- 503A Facility, Lowlyn Pharmacies, Inc. (dba Red Cross Drug), Blanchard, OK- 503A Facility, Lynnfield Drug, Inc. (dba Freedom Fertility Pharmacy), Byfield, MA- 503A Facility, Lynn Oaks Compounding Pharmacy, Thousand Oaks, CA - 503A Facility, M Drug, LLC, (dba Northern Light Pharmacy), Bangor, ME- 503A Facility, Maag Prescription Center LLC, Pocatello, ID- 503A Facility, Madison Drugs (see Service First Pharmacies, Inc.), Huntsville, AL- 503A Facility, Magellan Rx Pharmacy LLC, Astoria, NY- 503A Facility, Maimonides Medical Center-Pharmacy, Brooklyn, NY- 503A Facility, Main Street Family Pharmacy, Newbern, TN- 503A Facility - Out of business, Maitland Labs of Central Florida, Orlando, FL- 503A Facility - Out of business, Malley's Compounding Pharmacy, (see Columbia River Pharmacy, LLC), Richland, WA- 503A Facility, Malanda, Inc., (dba Mandell's Clinical Pharmacy), Somerset, NJ- 503A Facility, Maplerose Enterprises, LLC (dba Pencol Pharmacy), Denver, CO- 503A Facility, Mark Drugs Pharmacy, (see Snyder Mark Drugs Roselle, Inc.), Roselle, IL- 503A Facility, Martin Avenue Pharmacy, Inc., Naperville, IL- 503A Facility, Maryland Specialty and Compounding, LLC dba Professional Arts Pharmacy, Baltimore, MD- 503A Facility - Ceased sterile compounding, MasterPharm LLC. Id. Ferrara v. Walters,919 So.2d 876, 886 (Miss. 13. Filed: August 27, 2021. We engage with your physician to offer the highest standard of care. Advanced Infusion Solutions. advanced infusion solutions lawsuit - beckoning-cat.com Fax: 601-988-1701. Id. Report any scam, fraud, complaint or review on any type of company, individual, service or product here. One of the HCPCS procedure codes in the Agreement is "HCPCS Code S9328". If you are not a monthly . 2:23-CV-10279 | 2023-02-02, U.S. District Courts | Contract | The Court has the authority to "declare the rights and other legal relations of any interested party seeking such declaration" pursuant to the Declaratory Judgment Act. (877) 443-4006. And by breaching the Agreement, AIS caused BCBS to wrongfully pay the S9328 code. BCBS and AHS allege they "entered into the Agreement for the purpose of contracting with AIS to provide home infusion therapy services to its members pursuant to the terms of the Agreement." advanced infusion solutions lawsuit - masrooi.com ADVANCED HEALTH SYSTEMS, INC. and BLUE CROSS & BLUE SHIELD OF MISSISSIPPI, A MUTUAL INSURANCE COMPANY, Defendants. 17. Plaintiff / Appellant: Randy Denning. 21-30534 | 2021-08-27, U.S. District Courts | Contract | 33. This docket was last retrieved on July 6, 2021. (Werner, Paul) (Entered: 03/11/2021), (#9) MOTION for Default Judgment as to Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions by Blue Cross Blue Shield of Michigan. (Winsten, I.) [21-30534] (Imad Sayed Matini ) [Entered: 09/13/2021 03:45 PM], APPEARANCE FORM received from Mr. Paul Anthony Werner, III for Bond Pharmacy, Incorporated for the court's review. Because the Counterclaim provides enough particularity to provide AIS with notice, the Court denies AIS's motion on this claim. AIS argues that BCBS and AHS merely provide a "formulaic recitation of the elements." ), Blue Cross Blue Shield of Michigan v. Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions, (#25) TRANSCRIPT of Hearing on Defendant's Motion to Dismiss held on 06/23/2021. Nora Apothecary and Alternative Therapies, Inc. 2008) (quoting Hughes v. The Tobacco Inst., Inc.,278 F.3d 417, 420 (5th Cir. advanced infusion solutions lawsuit - auscap.net You can reach out to the office of Advanced Infusion Solutions via phone at (877) 443-4006 . Request information The remainder equals $8.80 a day. Lists Featuring This Company Texas Health Care Companies (Top 10K) 9,875 Number of Organizations $24.7B Total Funding Amount 1,718 Number of Investors Track A more recent docket listing Advanced Infusion Services | 114 seguidores en LinkedIn. 869, Km 2.0, Calle 19, Solar 1-A Palmas Industrial Park Catao, P.R. (Attachments: #1 Exhibit Exhibit 1) (Knapp, Scott) (Entered: 04/28/2021), (#20) NOTICE OF HEARING BY VIDEO CONFERENCE on #18 MOTION to Dismiss Plaintiff's Amended Complaint. Salaries below this are outliers. Lawyers for Pharmaceutical Research and Manufacturers of America and U.S. Health and Human Services Secretary Xavier Becerra on Friday jointly asked U.S . Id. A party, however, does not breach the covenant when "the party took only those actions which were duly authorized by the contract." Mississippi, Northern Division.https://leagle.com/images/logo.png. 15. [Previously dismissed case: No] [Possible companion case(s): None] (Moody, Nolan) (Entered: 01/11/2021). 2:21-CV-12966 | 2021-12-20. Find more than 21 complaints| Ripoff Report. (Court Reporter/Transcriber: Sheri Ward, www.transcriptorders.com) (Number of Pages: 21) The parties have 21 days to file with the court and Court Reporter/Transcriber a Redaction Request of this transcript. Thus, the Court denies AIS's motion on this claim. Closure of pain-only practices impacts thousands of patients - WITI Repair Your Reputation The Right Way Corporate Advocacy Program advanced infusion solutions lawsuit. Yes. Infusion Solutions - Home [21-30534] (Imad Sayed Matini ) [Entered: 09/13/2021 04:00 PM], APPEARANCE FORM for the court's review. AIS Healthcare - Crunchbase Company Profile & Funding Advanced Infusion Care Clinton 132 Fairmont Street, Suite B Clinton, MS 39056 P: 601.988.1710 I 888.339.2144 F: 229.242.9914 I 844.259.0209 URAC accredited for Specialty Pharmacy Advanced Infusion Care Valdosta 212 Northside Drive Valdosta, GA 31602 P: 229.242.3060 | 800.482.8466 F: 229.242.9914 URAC accredited for Specialty Pharmacy Lead Counsel? Ct. App. VP, Managed Care (Former Employee) - Ridgeland, MS - May 12, 2020 See Order [61]. Sufficient Mtn/Resp/Reply due on 10/26/2021 for Appellant Randy Denning. A subscription to PACER is required. R. Civ. 47. [21-30534] (Timothy Richardson ) [Entered: 09/14/2021 09:49 AM], APPEARANCE FORM for the court's review. Contacts. Id. Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions Case Summary On 01/11/2021 Blue Cross Blue Shield of Michigan filed a Contract - Insurance lawsuit against Bond Pharmacy, Inc d/b/a Advanced Infusion Solutions. (Ward, S) (Entered: 07/06/2021), DocketMinute Entry for proceedings before District Judge Denise Page Hood: Motion Hearing held on 6/23/2021 re #18 MOTION to Dismiss Plaintiff's Amended Complaint filed by Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions Disposition: Motion taken under advisement (Court Reporter: Sheri Ward) (LSau) (Entered: 06/24/2021), Docket(#24) REPLY to Response re #18 MOTION to Dismiss Plaintiff's Amended Complaint filed by Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. [21-30534] (DDL) [Entered: 09/17/2021 02:01 PM], ELECTRONIC RECORD ON APPEAL REQUESTED from District Court for 2:21-CV-774. Lead Counsel? This Court dismissed the ERISA claims. [59] at 16. (Cloutier, Kevin) (Entered: 04/29/2021), (#21) RESPONSE to #18 MOTION to Dismiss Plaintiff's Amended Complaint filed by Blue Cross Blue Shield of Michigan. advanced infusion solutions lawsuit Ct. App. Docket for Advanced Reimbursement Solutions LLC v. Aetna Life Insurance Company, 2:19-cv-05395 Brought to you by the RECAP Initiative and Free Law Project, a non-profit dedicated to creating high quality open legal information. [21-30534] (Roberta Louise Burns ) [Entered: 09/14/2021 10:55 AM], APPEARANCE FORM for the court's review. Denning v. Bond Pharmacy, Inc. - PacerMonitor The medication in the pump lasts between a week and several months without requiring the patient to see a healthcare provider. PDF United States Court of Appeals for the Fifth Circuit Signed by District Judge Denise Page Hood. ADVANCED INFUSION SOLUTIONS. [21-30534] REVIEWED AND/OR EDITED - The original text prior to review appeared as follows: UNOPPOSED MOTION filed by Appellant Mr. Randy Denning to supplement the record on appeal with Reasons in Support of Order granting Motion to Dismiss [9692325-2]. Commc'ns, Inc. v. Banks,90 So.3d 1221, 1224 (Miss. Citations are also linked in the body of the Featured Case. [21-30534] (DLJ) [Entered: 08/27/2021 12:27 PM]. Before the Court is Advanced Infusion Solutions' ("AIS") Motion to Dismiss the Counterclaim filed by Blue Cross & Blue Shield of Mississippi ("BCBS") and Advance Health Systems ("AHS") [56]. Advanced Infusion Solutions is a medicare enrolled Durable Medical Equipment & Medical Supplies Supplier in Dallas, Texas. Referral Letter to the Arizona Board of Pharmacy Issued 03/30/2015, Referral Letter to the Virginia Board of Pharmacy Issued 10/27/2016, Referral Letter to Virginia Board of Pharmacy Issued 08/13/2013, Referral Letter to the California State Board of Pharmacy Issued 09/29/2020, Referral Letter to the California State Board of Pharmacy Issued 12/27/2020, Referral Letter to the California State Board of Pharmacy Issued 07/08/2019, Referral Letter to the Alabama State Board of Pharmacy Issued 08/14/17, State Referral Letter to the Washington State Department of Health Issued 04/18/2018, Referral Letter to New York State Board of Pharmacy Issued 04/21/2015, Referral Letter to the California State Board of Pharmacy Issued 06/23/2015, Referral Letter to the New Jersey State Board of Pharmacy Issued 01/03/2017, Referral Letter to the Texas State Board of Pharmacy Issued 09/21/2020, Referral Letter to the Texas State Board of Pharmacy Issued 04/24/2019, Referral Letter to the South Carolina Department of Labor and Licensing- Board of Pharmacy Issued 02/15/2017, Referral to the Florida State Board of Pharmacy Issued 07/28/2017, Referral Letter to the Illinois State Board of Pharmacy Issued 05/05/2020, Referral Letter to the Tennessee Board of Pharmacy Issued 02/06/2019, Referral Letter to the New York State Board of Pharmacy Issued 01/09/2017, Referral Letter to Washington State Board of Pharmacy Issued 08/01/2017, Referral Letter to Utah State Board of Pharmacy Issued 02/20/2014, Referral Letter to the Arizona State Board of Pharmacy dated 02/06/2020, Referral Letter to the Minnesota State Board of Pharmacy Issued 10/22/2019, Referral Letter to the Alabama State Board of Pharmacy Issued 04/15/2015, Referral Letter to the Illinois State Board of Pharmacy Issued 04/03/2019, Referral to the New York City Department of Health and Mental Hygiene Issued 08/08/2017, Referral Letter to the Connecticut Commission of Pharmacy Issued 03/25/2015, FDA Statement: FDA Alerts Pharmacies to Concerns with Testing Conducted by Front Range Laboratories, See FDA's Enforcement Report to Search Recalls, Including Compounded Drug Products, Inspections, Recalls, and Other Actions with Respect to Firms that Engage in Animal Drug Compounding. $52,000 - $65,999 10% of jobs $66,000 - $79,999 13% of jobs The average salary is $93,518 a year $80,000 - $93,999 13% of jobs $94,000 - $107,999 12% of jobs (Attachments: #1 Index of Exhibits, #2 Exhibit 1 - BCBS Agreement, #3 Exhibit 2 - Letter from BCBS, #4 Exhibit 3 - Letter from Sheppard Mullin) (Winsten, I.) Human Drug Compounding, Recalls, Market Withdrawals and Safety Alerts, Compounding Quality Center of Excellence On-demand Training, Compounding Oversight and Compliance Actions, Compounding: Inspections, Recalls, and other Actions, Consumer and Health Care Professional Information, Guidance, Compliance, & Regulatory Information, 2014 - 2015 Compounding: Inspections, Recalls, and other Actions, Referral Letter to the California State Board of Pharmacy Issued 07/06/2020, Referral Letter to the Florida State Board of Pharmacy Issued 02/15/2017, Referral Letter to the Virginia State Board of Pharmacy dated 01/29/2020, Referral Letter to the Missouri Board of Pharmacy dated 06/16/2022, Referral Letter to the Nevada State Board of Pharmacy dated 07/13/2022, Referral Letter to the Virginia State Board of Pharmacy Issued 06/08/2017, Referral Letter to the New York State Board of Pharmacy Issued 05/08/2017, Referral Letter to the Delaware State Board of Pharmacy Issued 04/28/2017, Referral Letter to Florida State Board of Pharmacy Issued 10/09/2015, Referral Letter to the New York State Board of Pharmacy Issued 03/22/2017, Referral Letter to Florida Board of Pharmacy Issued 02/21/2014, Referral Letter to State of New Hampshire Board of Pharmacy Issued 06/07/2016, Referral Letter to the Kansas State Board of Pharmacy Issued 03/06/2019, Referral Letter to the North Carolina State Board of Pharmacy Issued 08/19/2019, Referral Letter to the Arizona State Board of Pharmacy Issued 04/09/2020, Referral to the Rhode Island State Board of Pharmacy Issued 07/25/2017, Referral Letter to the California State Board of Pharmacy Issued 08/31/2017, Referral to the New York State Board of Pharmacy Issued 11/16/2017, Referral Letter to the Mississippi Board of Pharmacy Issued 08/02/2016, Referral Letter to the Ohio State Board of Pharmacy Issued 10/29/2019, Referral Letter to the Ohio State Board of Pharmacy Issued 05/01/2019, Referral Letter to the Florida Board of Pharmacy Issued on 01/31/17, Referral Letter to the Georgia State Board of Pharmacy Issued 11/18/2019, Referral to the Connecticut State Board of Pharmacy Issued 07/12/2017, Referral Letter to the Louisiana Board of Pharmacy Issued 11/03/2022, Referral Letter to the Michigan Board of Pharmacy Issued 03/22/2017, Referral Letter to the Ohio State Board of Pharmacy Issued 08/09/17, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 01/17/17, Referral Letter to the California State Board of Pharmacy Issued 07/20/2020, FDA Alerts Health Care Professionals and Patients not to Use Sterile Drug Products from Chen Shwezin Inc., dba Park Compounding Pharmacy, Referral Letter to the Michigan Board of Pharmacy Issued 09/09/16, Referral Letter to the Ohio Board of Pharmacy Issued 05/30/2014, Referral Letter to the Mississippi State Board of Pharmacy Issued 11/05/2019 Shutdown Letter, Referral Letter to the Mississippi Board of Pharmacy Issued 06/27/2019, Referral Letter to the Georgia State Board of Pharmacy Issued 02/15/2017, Referral Letter to the Indiana State Board of Pharmacy Issued 10/02/2019, Referral Letter to the Arkansas State Board of Pharmacy Issued 10/28/2020, Referral Letter to the California State Board of Pharmacy Issued 12/14/2015, Leader of $17 Million Health Insurance Fraud Scheme Ordered to Prison, Referral Letter to the Texas State Board of Pharmacy Issued 05/18/2020, FDA Requested Recall Letter Issued 09/09/2014, FDA Requested Recall Letter Issued 07/26/2013, Referral Letter to New Jersey State Board of Pharmacy Issued 02/21/2014, Referral Letter to the Georgia State Board of Pharmacy Issued 05/19/2020, Referral Letter to the Minnesota State Board of Pharmacy Issued 04/29/2019, FDA warns patients and health care professionals not to use sterile products from North American Custom Laboratories LLC, dba FarmaKeio Superior Custom Compounding, Referral Letter to Missouri Board of Pharmacy Issued 02/26/2014, Referral Letter to the Alaska State Board of Pharmacy dated 02/18/2020, Referral Letter to the Alaska State Board of Pharmacy dated 02/06/2020, Referral Letter to the Tennessee Board of Pharmacy Issued 02/08/2017, FDAs Investigation into Guardians Compounded Triamcinolone-Moxifloxacin Drug Product, FDA Alerts Health Care Professionals of Adverse Events Associated with Guardians Compounded Triamcinolone and Moxifloxacin Product for Intravitreal Injection, Corrected (No Redactions) 483 Issued 10/21/2016, Referral Letter to the Texas State Board of Pharmacy Issued 03/24/2021, Referral to the California State Board of Pharmacy Issued 09/26/2017, Referral Letter to the Michigan State Department of Licensing and Regulatory Affairs (LARA) Issued 05/21/2015, Referral Letter to the Florida State Board of Pharmacy Issued 01/23/2017, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 03/27/2014, Referral Letter to the Texas State Board of Pharmacy Issued 05/05/2016, Referral Letter to the Maryland State Board of Pharmacy Issued 08/23/2019, A Case of Hemorrhagic Occlusive Retinal Vasculitis (HORV) Following Intraocular Injections of a Compounded Triamcinolone, Moxifloxacin, and Vancomycin Formulation, FDA Investigates Two Serious Adverse Events Associated with ImprimisRxs Compounded Curcumin Emulsion Product for Injection, Investigation Memo and Attachments, 08/16/2011, Referral Letter to the Minnesota State Board of Pharmacy Issued 07/01/2019, Referral to the South Carolina State Board of Pharmacy Issued 09/13/2017, Referral Letter to the Ohio Board of Pharmacy Issued 03/28/2019, Referral Letter to the ColoradoBoard of Pharmacy Issued 12/23/2020, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 10/03/2019, Referral Letter to the New Mexico State Board of Pharmacy Issued 08/22/2017, Maxor National Pharmacy Services Corporation, Referral Letter to the Texas Board of Pharmacy Issued 03/18/2014, Alexandria Medical Arts Pharmacy & Compounding Laboratory, Referral Letter to the Florida Board of Pharmacy Issued 04/21/2017, FDA announces Glades Drugs nationwide voluntary recall of Compounded Multivitamins containing High Amounts of Vitamin D3 (Cholecalciferol), Referral Letter to the California State Board of Pharmacy Issued 12/06/2019, Referral Letter to the Missouri State Board of Pharmacy Issued 01/10/2017, Referral Letter to the Missouri State Board of Pharmacy Issued 03/10/2016, Referral Letter to the Ohio State Board of Pharmacy Issued 08/11/2015, Referral Letter to the Illinois State Board of Pharmacy Issued 09/11/2019, Referral Letter to the New York State Board of Pharmacy Issued 11/15/2019, Referral Letter to the California State Board of Pharmacy Issued 11/22/2019, Referral Letter to the Nebraska State Board of Pharmacy Issued 07/11/2019, Referral Letter to Oklahoma State Board of Pharmacy Issued 02/25/2014, Referral Letter to the New York State Board of Pharmacy Issued 06/06/2019, Referral Letter to the Massachusetts Department of Public Health Issued 10/14/2015, Referral to the New York State Education Department, Office of the Professions, Pharmacy Issued 07/07/2017, Referral Letter to the Minnesota State Board of Pharmacy Issued 04/10/2019, Referral Letter to the Oklahoma State Board of Pharmacy Issued 10/2/2020, Referral Letter to the Missouri Board of Pharmacy Issued 02/18/2015, FDA Requested Recall Letter Issued 05/03/2016, Referral Letter to the South Carolina State Board of Pharmacy Issued 05/21/2015, Referral to the Texas State Board of Pharmacy Issued 07/28/2017, State Referral Letter to the Nevada State Board of Pharmacy issued 12/06/2017, Referral Letter to Massachusetts Board of Registration in Pharmacy Issued 01/20/2016, Barclay Luke & Pillai Specialty Pharmacy PLLC, Referral Letter to the Arizona State Board of Pharmacy Issued 05/23/2017, Referral Letter to the Michigan State Board of Pharmacy Issued 06/13/2019, Referral Letter to the Tennessee Board of Pharmacy Issued 04/05/2017, Referral Letter to the Wisconsin State Board of Pharmacy Issued 06/13/2019, Referral Letter to the Nebraska State Board of Pharmacy Issued 05/09/2016, Unlicensed Pharmacy Technician Sentenced for Working at New England Compounding Center, Owner and Four Former Employees of New England Compounding Center Convicted Following Trial, Unlicensed Pharmacy Technician Pleads Guilty to Working at New England Compounding Center, Compounding Pharmacy Owner Sentenced to Five Years in Prison for $10.5 Million Health Care Fraud, Multistate outbreak of fungal meningitis and other infections, Referral to the Massachusetts State Board of Registration in Pharmacy Issued 09/26/2017, Referral Letter to New Hampshire State Board of Pharmacy Issued 04/29/2015, Referral Letter to the Kentucky State Board of Pharmacy Issued 03/04/2020, Referral to the Kansas State Board of Pharmacy Issued 06/28/2017, Referral Letter to the Illinois State Board of Pharmacy Issued 07/01/2020, Referral Letter to the Illinois State Board of Pharmacy Issued 10/31/2019, Referral Letter to the California State Board of Pharmacy Issued 07/08/2020, Referral Letter to Florida State Board of Pharmacy Issued 03/10/2021, Amended 483 and Cover Letter Issued 04/09/2013 and 483 Issued 03/29/2013, Referral Letter to the Tennessee State Board of Pharmacy Issued 09/13/2019, Referral Letter to the Florida State Board of Pharmacy Issued 04/22/2019, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 05/05/2017, Pentec Health Announces Limited Voluntary Recall of Certain Compounded Prescription Therapies for Renal Patients, Referral Letter to the Texas State Board of Pharmacy Issued 03/12/2019, Referral Letter to the Kansas State Board of Pharmacy Issued 03/29/2017, Pharmacy Creations Issues Voluntary Recall of Four Product Lots With Limited Distribution in Florida, New Jersey, New York, and Puerto Rico Due to Potential Non-Sterility (09/04/2014), Referral Letter to the Indiana State Board of Pharmacy Issued 03/06/2017, Pharmacy Owner and Director of Compliance Charged with Defrauding United States and Distributing Adulterated Drugs, Referral Letter to the New Jersey State Board of Pharmacy Issued 07/29/2019, Referral to the Oklahoma State Board of Pharmacy Issued 07/28/2017, Referral Letter to the Georgia State Board of Pharmacy Issued 08/14/2020, Referral Letter to New York State Board of Pharmacy Issued 11/07/2016, Referral Letter to the New Jersey State Board of Pharmacy Issued 01/11/2017, Referral Letter to Michigan Board of Pharmacy Issued 02/25/2014, Referral Letter to the California State Board of Pharmacy Issued 04/05/2017, Referral Letter to the Colorado State Board of Pharmacy Issued 04/14/2020, Referral Letter to the FloridaBoard of Pharmacy Issued 07/27/2022, Referral Letter to the Ohio State Board of Pharmacy Issued 09/12/2019, Referral to the New York State Board of Pharmacy Issued 06/15/2017. (Attachments: #1 Index of Exhibits, #2 Exhibit 1 - Home Infusion Therapy Facility Participation Agreement, #3 Exhibit 2 - October 6, 2020 Letter from M. Martinez to J. Finley, #4 Exhibit 3 - October 16, 2020 Letter from P. Werner to M. Martinez) (Winsten, I.) Industry: Health maintenance organization , Drug stores and proprietary stores Printer Friendly View Address: 623 Highland Colony Pkwy Ste 100 Ridgeland, MS, 39157-6077 United States See other locations Phone: Website: www.aiscaregroup.com Employees (this site): Actual ESG industry average: What is D&B's ESG Ranking? Date of service: 10/19/2021 via email - Attorney for Appellants: Burns, Camel, Richardson; Attorney for Appellees: Matini, Patron, Spencer-Davis, Werner [21-30534] (Roberta Louise Burns ) [Entered: 10/19/2021 02:16 PM], APPEARANCE FORM for the court's review. Mississippi, Northern Division. Blog 16. (Winsten, I.) Signed by District Judge Denise Page Hood. The plausibility standard does not ask for a probability of unlawful conduct but does require more than a "sheer possibility." Advanced Reimbursement Solutions LLC - CourtListener.com Because BCBS and AHS may plead unjust enrichment in the alternative, the Court does not dismiss this claim. United States District Court, S.D. Cause No. Good faith means "the faithfulness of an agreed purpose between two parties, a purpose which is consistent with justified expectations of the other party." United States District Court, S.D. Docket alerts are an advanced feature of CourtListener. BOND PHARMACY v. ADVANCED | Civil Action No. 3 | 20220208c45| Leagle.com The basis for the action "lies in a promise, which is implied in law, that one will pay to the person entitled thereto [that] which in equity and good conscience is his." 13. No. BCBS is an insurance company in Mississippi. [57] at 16. (Entered: 01/28/2021), (#4) ATTORNEY APPEARANCE: Scott R. Knapp appearing on behalf of Blue Cross Blue Shield of Michigan (Knapp, Scott) (Entered: 01/21/2021), (#3) SUMMONS Issued for *Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions* (NAhm) (Entered: 01/12/2021), (#2) STATEMENT of DISCLOSURE of CORPORATE AFFILIATIONS and FINANCIAL INTEREST by Blue Cross Blue Shield of Michigan (Moody, Nolan) (Entered: 01/11/2021), (#1) COMPLAINT filed by Blue Cross Blue Shield of Michigan against Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. Click on the case name to see the full text of the citing case. NOA filed by Appellant Mr. Randy Denning. For the reasons stated, the Court DENIES AIS's Motion to Dismiss Counterclaim [56]. Ridgeland, MS 39157. miles away. Id. 2:19-CV-02695 | 2019-06-20, U.S. District Courts | Civil Right | Our inspiration came from the infusion experiences of our close family: Annette's brother and Lucien's father. 2010).

Maine Dealer Temp Plates, Ceramic Bowl For Kneading Dough, Strasbourg Cathedral Facts, Breaking News Hampton Va Shooting, Socalgas Personality Test, Articles A